Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.

Gynecologic oncology - 1 Sept 2015

Garcia Christine, Lyon Liisa, Conell Carol, Littell Ramey D, Powell C Bethan

Abstract excerpt

OBJECTIVE: Characterize current management of osteoporosis risk in BRCA carriers following risk-reducing salpingo-oophorectomy (RRSO). METHODS: Women with a BRCA1 or BRCA2 mutation who underwent RRSO were identified from a community-based health system in Northern California from 1995 to 2012. Retrospective chart review using the electronic medical record was performed. The primary outcome was the number of women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteoporosis

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Salpingectomy

Share to United States

Source

Identifiers

PMID: 26086567
DOI: 10.1016/j.ygyno.2015.06.020

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.PMID 26086567Read ↗

Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.Semantic proximity Read ↗

Changes in Bone Density in Carriers of BRCA1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy.Semantic proximity Read ↗

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.Semantic proximity Read ↗

Female reproductive factors, genetic susceptibility and incident osteoporosis risk.Semantic proximity Read ↗

Osteoporosis in young adults: pathophysiology, diagnosis, and management.Semantic proximity Read ↗

Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.Semantic proximity Read ↗

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.Semantic proximity Read ↗

Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers.Semantic proximity Read ↗

Endocrine-related osteoporosis: bone quality, clinical phenotype, and targeted management.Semantic proximity Read ↗

Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2.Semantic proximity Read ↗

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.